As Kamala Harris crisscrossed battleground states with ultra-right warmonger Liz Cheney, Vermont Senator Bernie Sanders ...

The global APOL1-mediated kidney disease market is poised for substantial expansion, with projections indicating a remarkable ...

WACO, Texas (KWTX) - Officials toured the Mountainview campus Wednesday morning to evaluate the space where a STEM lab will ...

Plus: Groupon cofounder’s healthcare venture, investments in CAR-T therapies and the upcoming Forbes Healthcare Summit.

In a report released today, Christopher Raymond from Piper Sandler maintained a Buy rating on AbbVie (ABBV – Research Report), with a ...

AbbVie should report strong Q3 2024 results next week and increase the full-year guidance. Explore more details here.

The hidradenitis suppurativa (HS) treatment market is set to surpass USD 763.6 million in 2023 and is projected to reach an ...

The U.S. Food and Drug Administration has approved AbbVie's Vyalev (foscarbidopa and foslevodopa) for adults living with ...

David Risinger, an analyst from Leerink Partners, maintained the Hold rating on AbbVie (ABBV – Research Report). The associated price ...

AbbVie (ABBV) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Neurologist Jason Aldred helped conduct trials for the device in Spokane through his work at Selkirk Neurology, where he ...